12 31
 
  Latest News
22nd Nov, 2011. Publication of PCT appli

Giantcode Corporations inte Read More..

18th November 2011. Delisting and resubm

Dear Shareholders, The shar Read More..

Read All News
 
 
Investors
 

Giantcode is a biotech company focused on revolutionising cancer treatment based on our patent pending technologies. The company is located in London, U.K., and has dedicated its attention towards fighting deadly diseases and restoring health. Our goal is to enhance the lives of patients by discovering and developing breakthrough treatments for various cancer forms

Giantcode Corporation values an open dialogue with existing and new investors. Our fast progress towards marketing the GC117 technology represents an attractive investment opportunity and we appreciate being contacted on this issue.

 
 
  Investors
 

 
  Quick Inquiry  
 
Name*
Email*
Phone*
City*
Query
 
 
 
 

Copyright @ 2010 Giantcode Corporation. All rights reserved.

Home  |     Corporate  |     Careers  |     Disclaimer  |     Sitemap

Subscribe to our Newsletter
Submit